Veterinary clinical pathologists are well positioned via education and training to assist in investigations of unexpected results or increased variation in clinical pathology data. Errors in testing and unexpected variability in clinical pathology data are sometimes referred to as ''laboratory errors.'' These alterations may occur in the preanalytical, analytical, or postanalytical phases of studies. Most of the errors or variability in clinical pathology data occur in the preanalytical or postanalytical phases. True analytical errors occur within the laboratory and are usually the result of operator or instrument error. Analytical errors are often ≤10% of all errors in diagnostic testing, and the frequency of these types of errors has decreased in the last decade. Analytical errors and increased data variability may result from instrument malfunctions, inability to follow proper procedures, undetected failures in quality control, sample misidentification, and/or test interference. This article (1) illustrates several different types of analytical errors and situations within laboratories that may result in increased variability in data, (2) provides recommendations regarding prevention of testing errors and techniques to control variation, and (3) provides a list of references that describe and advise how to deal with increased data variability.Keywords laboratory testing errors, analytical errors, unexpected data variation, quality control, clinical pathology Veterinary clinical pathologists who work in the biopharmaceutical industry often have primary responsibilities that include description and interpretation of clinical and morphologic pathology data from animals used in drug safety studies, hazard identification, and risk assessment. These responsibilities may extend from early drug discovery studies to human clinical trials. In addition, veterinary clinical pathologists may serve as scientific resources within a company, provide diagnostic support, manage laboratories, and assist in evaluation of innovative biomarkers and new technologies in drug development (Schultze, Bounous, and Bolliger 2008). Veterinary clinical pathologists often work very closely with laboratory staff members to counsel colleagues and clients regarding unexpected laboratory test results. These discussions can be challenging and may involve exploration of causes for increased or undesirable variability and irregularities in the data used in drug development studies.Suspected increased variability in clinical pathology data and diagnostic testing errors are often referred to using the general term of ''laboratory error.'' Diagnostic testing errors and practices that cause increased variability in clinical pathology data may occur during all stages of testing (preanalytical phase, analytical phase, and postanalytical phase; Moore and Barger 2016). Errors in the preanalytical phase occur prior to sample analysis and are generally external to the clinical pathology laboratory. In preanalytical errors, the analysis of the sample...